Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Administration of Cannabidiol and L-Theanine Improves Sleep-Related Outcomes in Caffeine-Induced Sleep Disturbances Mouse Model.

Biomolecules & therapeutics·2026
Same author

Behavioral and Biochemical Evaluation of a Curcumin-Loaded Nano-Liposomal Formulation in a Scopolamine-Induced Mouse Model of Cognitive Impairment.

Biomolecules & therapeutics·2026
Same author

Enhanced bioavailability of a novel double-layered nano-liposomal curcumin (BNT-C060): a randomized, double-blind, clinical trial.

Scientific reports·2026
Same author

Corrigendum to "Sodium nitroprusside induces apoptosis of H9C2 cardiac muscle cells in a c-Jun N-terminal kinase-dependent manner" [Int. Immunopharmacol. 1 (2001) 967-978].

International immunopharmacology·2026
Same author

AI and experimental convergence: a synergistic pathway to JAK2 inhibitor discovery.

Acta pharmacologica Sinica·2026
Same author

D-Allulose Regulates Obesity via Endoplasmic Reticulum Stress-Mediated Glucagon-Like Peptide-1 Receptor Pathway.

Antioxidants & redox signaling·2025

Related Experiment Video

Updated: Jun 16, 2026

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

Measuring adriamycin-induced cardiac hemodynamic dysfunction with a proteomics approach.

Yan Cui1, Cheng-Shi Piao, Ki-Chan Ha

  • 1Department of Pharmacology, Medical School, Chonbuk National University, Jeonju, Republic of Korea.

Immunopharmacology and Immunotoxicology
|January 29, 2010
PubMed
Summary

Adriamycin, an antitumor drug, increases heart damage susceptibility by altering cardiac protein expression, particularly in energy metabolism and cytoskeleton. This proteomics study reveals key protein changes linked to cardiotoxicity.

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

Area of Science:

  • Biochemistry
  • Cardiology
  • Proteomics

Background:

  • Adriamycin is a vital antitumor medication.
  • Adriamycin-induced cardiotoxicity presents a significant clinical challenge.
  • The precise mechanisms underlying adriamycin cardiotoxicity remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms of adriamycin cardiotoxicity using a proteomics approach.
  • To identify specific protein expression changes in the heart following adriamycin administration and hemodynamic alterations.

Main Methods:

  • Proteomics analysis was employed to examine protein profile alterations in cardiac tissue.
  • Hemodynamic parameters including left ventricular developed pressure (LVDP) and left ventricular end diastolic pressure (LVEDP) were monitored.
  • The study assessed susceptibility to ischemia-reperfusion injury post-Adriamycin treatment.

Main Results:

  • Adriamycin treatment altered the expression of 52 cardiac proteins.
  • Key proteins involved in energy metabolism (e.g., ATP synthase, pyruvate dehydrogenase) and cytoskeletal structure (e.g., actin) showed decreased expression.
  • Adriamycin enhanced cardiac susceptibility to ischemia-reperfusion-induced hemodynamic dysfunction.

Conclusions:

  • Adriamycin significantly impacts cardiac energy metabolism and cytoskeletal protein expression.
  • These molecular alterations may contribute to the observed cardiotoxicity and hemodynamic changes.
  • Proteomics provides valuable insights into the mechanisms of drug-induced cardiac damage.